Definitive Contract 75N93019C00046
Award Date 9/11/19
Potential Completion Date 9/29/24
Potential Value $9M
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
New York, NY 10029, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award for $18,472,563.99 was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Montana. The contract's objective is to identify novel adjuvant candidates that can be used to augment the efficacy of human vaccines. Research under this definitive, cost-no-fee contract will contribute to the pipeline of new adjuvant leads that either exploit the innate immune system or act directly...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to the Icahn School of Medicine at Mount Sinai, a private medical school in New York City. The contract is for the development of vaccine candidates for biodefense, antimicrobial resistant infections, and emerging infectious diseases, with a potential value of $22,709,915.00. It is a definitive, cost-no-fee contract with a completion date...
- The Icahn School of Medicine at Mount Sinai received a $151.4M definitive contract from the National Institute of Allergy and Infectious Diseases to support Component A of the Collaborative Influenza Vaccine Innovation Centers (CIVICS) program. The initiative aims to design and evaluate innovative influenza vaccine approaches based on principles of influenza immunity to achieve durable, robust protection against influenza infection. This cost-plus-no-fee contract runs through September 24, 2026,...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $42,132,619.00 definitive contract to the Icahn School of Medicine at Mount Sinai (ISMMS) for the NIAID Centers of Excellence for Influenza Research and Surveillance program. This cost-no-fee contract, awarded on March 30, 2007, has a performance period ending on May 23, 2017. ISMMS, a private university and non-profit organization, will...
- This federal contract award to the Icahn School of Medicine at Mount Sinai (ISMMS) was made by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct research on "Modeling Immunity for Biodefense". The $17,219,467.21 cost-no-fee contract has a period of performance from September 30, 2010 to September 29, 2015 and does not have a set-aside designation. Under this award, ISMMS is collaborating with several subcontractors, including the California Institute of...
- This federal contract award is to the Icahn School of Medicine at Mount Sinai (ISMMS), a renowned academic medical center and research institution in New York City. The contract, valued at $399,266.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to support the development of animal models of infectious diseases. The award is a delivery order under NIAID's larger "Animal Models of Infectious Diseases...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private university and non-profit educational institution. The $10,799,605.00 Definitive Contract is for BIOMEDICAL (BASIC) services, with a Firm Fixed Price pricing type. The contract has no set-aside designation and was awarded on August 17, 2009, with a completion date of September...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private academic medical center and research institution located in New York, NY. The $18,691,713.00 cost-no-fee definitive contract is for biomedical research services, with a period of performance ending on March 31, 2011. The contract does not have a set-aside designation....
- This is a $10,725,896 federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Oregon Health & Science University (OHSU). The contract is for the Vaccine Adjuvant Discovery Program, which aims to identify novel adjuvant candidates that can enhance the efficacy of human vaccines. The contract is a definitive, cost-no-fee contract with a performance period ending on March 31, 2026. No set-aside was...
- The Department of Health and Human Services' National Institute of Allergy and Infectious Diseases (NIAID) awarded a $9,896,692 Vaccine Adjuvant Discovery Program (VADP) contract to the University of Montana. The 5-year contract, which has no set-aside designation, aims to identify, characterize, and advance novel synthetic adjuvants for use in combination with bacterial and fungal antigens to induce a safe and durable T-helper 17 (Th17) and/or Th17/Th1 immune response. The University of Montana...